Clench Stapling System_Ixef PARA_Reign Medical

Solvay’s high-stiffness Ixef® PARA enables Reign Medical to develop a more robust compression staple system for orthopedic and podiatric surgeries

Solvay, a leading global supplier of specialty polymers, announced today that its Ixef® polyarylamide (PARA) resin delivered the high stiffness and biocompatibility that Reign Medical needed to develop its revolutionary new Clench® compression staple system, a single-use bone staple kit for orthopedic procedures targeting the hand and foot.


Solvay introduces innovations at WPC 2018, the world's largest fragrance trade show

To strengthen its presence in the international Air Care and Fragrance segments, Solvay is taking part to World Perfumery Congress (June 5 to 7 in Nice, France), introducing innovations and new applications of products with great potential in these markets, such as hexylene glycol (HGL) and Augeo Clean Multi solvents, both from the Coatis global business unit's portfolio, whose headquarters and research center are located in Brazil.

Participation notification by Blackrock Inc.

Brussels, Friday May 25, 2018, 08h30 CEST --- According to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.) has notified Solvay S.A. that: On May 17, 2018 BlackRock Inc. crossed upward the 3% statutory threshold for direct voting rights, holding 3.37%. Including equivalent financial instruments, the total voting rights stood at 4.88%. Declarations by BlackRock Inc. are published in the Investor Relations Section of Solvay's website.